A Clinician's Perspective on Emerging Therapies and Managed Care Challenges in Vitiligo Management : Episode 2
Exploring Emerging Therapies in Vitiligo
The panelist discusses how emerging targeted therapies like Janus kinase inhibitors and combination treatment approaches are transforming vitiligo management, with treatment selection guided by disease patterns, progression rates and individual patient response, while acknowledging the need for systematic assessment and alternative strategies for treatment-resistant cases.
Video content above is prompted by the following:
- What are the most promising new vitiligo treatments?
- How has this knowledge shaped current treatment approaches and new therapies?
- How do vitiligo progression patterns affect treatment decisions and long-term management?
- Describe your process to assess and manage treatment-resistant disease.
- What is the role of newer targeted therapies in such cases?
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
